Normal human serum contains high levels of anti-Galα1-4GlcNAc antibodies

被引:33
作者
Obukhova, Polina
Rieben, Robert
Bovin, Nicolai
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[2] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland
关键词
aGal epitope; carbohydrates; human antibodies; xenotransplantation;
D O I
10.1111/j.1399-3089.2007.00436.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Natural xenoreactive antibodies (Abs) directed against the B-di-epitope (Gal alpha 1-3Gal beta) on the cells of non-primate mammals take part in hyperacute rejection of xenotransplanted organs. We found that some Abs, which were one-step affinity purified on B-di-Sepharose, cross-reacted with the disaccharide Gal alpha 1-4GlcNAc beta. The epitope Gal alpha 1-4GlcNAc has not been identified on mammals or bacterial polysaccharides yet. Methods: To isolate the antibodies of the corresponding specificity the disaccharide was immobilized on Sepharose and antibodies were affinity purified from pooled serum of blood group O individuals. Results: These one-step purified Abs cross-reacted with B-di, but after a prior absorption step on B-di-Sepharose no cross-reactivity with B-di was observed any longer. Surprisingly, the quantity of anti-Gal alpha 1-4GlcNAc isolated from the same serum pool, 4-7 mu g/ml, was equal to that of anti-B-di or more. Independently of ABO blood groups all the tested healthy donors had anti-Gal alpha 1-4GlcNAc Abs at a similar level. Monospecific anti-Gal alpha 1-4GlcNAc Abs were not cytotoxic towards porcine cells. Conclusions: 1. The actual concentration of monospecific, xenoreactive Gal alpha 1-3Gal beta Abs in blood may be considerably lower than the value referred to in the literature for 'anti-alpha Gal' or 'anti-Galili' antibodies. 2. Anti-Gal alpha 1-4GlcNAc Abs seem not to be important for xenotransplantation.
引用
收藏
页码:627 / 635
页数:9
相关论文
共 21 条
[1]   Carbohydrate peptide mimics: effect on MUC1 cancer immunotherapy [J].
Apostolopoulos, V ;
Sandrin, MS ;
McKenzie, IFC .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05) :427-436
[2]   Printed covalent glycan array for ligand profiling of diverse glycan binding proteins [J].
Blixt, O ;
Head, S ;
Mondala, T ;
Scanlan, C ;
Huflejt, ME ;
Alvarez, R ;
Bryan, MC ;
Fazio, F ;
Calarese, D ;
Stevens, J ;
Razi, N ;
Stevens, DJ ;
Skehel, JJ ;
van Die, I ;
Burton, DR ;
Wilson, IA ;
Cummings, R ;
Bovin, N ;
Wong, CH ;
Paulson, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17033-17038
[3]   Polyacrylamide-based glycoconjugates as tools in glycobiology [J].
Bovin, NV .
GLYCOCONJUGATE JOURNAL, 1998, 15 (05) :431-446
[4]   SYNTHESIS OF POLYMERIC NEOGLYCOCONJUGATES BASED ON N-SUBSTITUTED POLYACRYLAMIDES [J].
BOVIN, NV ;
KORCHAGINA, EY ;
ZEMLYANUKHINA, TV ;
BYRAMOVA, NE ;
GALANINA, OE ;
ZEMLYAKOV, AE ;
IVANOV, AE ;
ZUBOV, VP ;
MOCHALOVA, LV .
GLYCOCONJUGATE JOURNAL, 1993, 10 (02) :142-151
[5]   Xenoantigens and xenoantibodies [J].
Cooper, DKC .
XENOTRANSPLANTATION, 1998, 5 (01) :6-17
[6]   Anti-α-galactosyl antibodies recognizing epitopes terminating with α1,4-linked galactose:: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies [J].
Duk, M ;
Kusnierz-Alejska, G ;
Korchagina, EY ;
Bovin, NV ;
Bochenek, S ;
Lisowska, E .
GLYCOBIOLOGY, 2005, 15 (02) :109-118
[7]   Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-α-galactosyl antibodies [J].
Duk, M ;
Westerlind, U ;
Norberg, T ;
Pazynina, G ;
Bovin, NN ;
Lisowska, E .
GLYCOBIOLOGY, 2003, 13 (04) :279-284
[8]   THE HUMAN NATURAL ANTI-GAL IGG .3. THE SUBTLETY OF IMMUNE TOLERANCE IN MAN AS DEMONSTRATED BY CROSS-REACTIVITY BETWEEN NATURAL ANTI-GAL AND ANTI-B ANTIBODIES [J].
GALILI, U ;
BUEHLER, J ;
SHOHET, SB ;
MACHER, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :693-704
[9]   A UNIQUE NATURAL HUMAN-IGG ANTIBODY WITH ANTI-ALPHA-GALACTOSYL SPECIFICITY [J].
GALILI, U ;
RACHMILEWITZ, EA ;
PELEG, A ;
FLECHNER, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05) :1519-1531
[10]  
GALILI U, 1999, SUBCELL BIOCH, V32